.

Pharmaceutical Business Intelligence

  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Goserelin acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for goserelin acetate?

Goserelin acetate is the generic ingredient in one branded drug marketed by Astrazeneca and is included in two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Goserelin acetate has forty-seven patent family members in thirty-three countries.

There are three drug master file entries for goserelin acetate. Two suppliers are listed for this compound.

Summary for Generic Name: goserelin acetate

Tradenames:1
Patents:3
Applicants:1
NDAs:2
Drug Master File Entries: see list3
Suppliers / Packagers: see list2
Bulk Api Vendors: see list22
Clinical Trials: see list481
Patent Applications: see list6,133
Therapeutic Class:Hormonal Agents, Suppressant (Pituitary)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:goserelin acetate at DailyMed

Pharmacology for Ingredient: goserelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes7,220,247► SubscribeY ► Subscribe
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes7,118,552► SubscribeY ► Subscribe
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes7,118,552► SubscribeY ► Subscribe
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes7,500,964► SubscribeY ► Subscribe
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes7,500,964► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: goserelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 19964,100,274► Subscribe
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 19895,366,734► Subscribe
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 19894,767,628► Subscribe
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 19964,767,628► Subscribe
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 19965,366,734► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: goserelin acetate

Country Document Number Estimated Expiration
Iceland2464► Subscribe
Estonia04662► Subscribe
Australia770373► Subscribe
Poland199979► Subscribe
Slovenia1259274► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc